Healthcare Industry News:  GeneraMedix 

Biopharmaceuticals Generics FDA

 News Release - August 9, 2007

GeneraMedix Inc. Announces FDA Approval and Launch of Ampicillin and Sulbactam for Injection, USP

LIBERTY CORNER, N.J., Aug. 9 (HSMN NewsFeed) -- GeneraMedix Inc. has received FDA approval and has launched Ampicillin and Sulbactam for Injection, USP.

GeneraMedix offers Ampicillin and Sulbactam for Injection, USP in 1.5 and 3 gram vials, preservative free.

This is the first product launched resulting from a long term, multi-product development and supply agreement between GeneraMedix Inc. and MN Pharmaceuticals, a leading pharmaceutical manufacturer based in Turkey.

Ronald F. Quadrel, President and CEO of GeneraMedix Inc. stated, "Our long term relationship with MN Pharmaceuticals is another cog in our overall strategy and ongoing commitment to provide our customers with high quality generic injectable products at a competitive price. It is my expectation that this relationship will yield a significant number of products that will help build the GeneraMedix portfolio in the immediate future as well as over the longer term."

M. Levent Selamoglu, CEO of MN Pharmaceuticals said, "This is an exciting and historical moment for MN Pharmaceuticals and the Turkish Pharmaceutical industry. The alliance with GeneraMedix Inc. has opened up the U.S. market to us. I strongly believe that this alliance will bring a new perspective to our company. The history of MN Pharmaceuticals is full of firsts in the Turkish Pharmaceutical Industry and we have added a significant one to that list by achieving this milestone."

About MN Pharmaceuticals

MN Pharmaceuticals is one of the leading and oldest pharmaceutical companies in Turkey. The company is a leading manufacturer of bulk pharmaceutical chemicals and finished dosage forms. MN has state-of the-art, high-capacity injectable and lyophilization facilities. The company received FDA approval of its API and parenteral manufacturing facilities in Istanbul, Turkey in January 2007. Additional information is available on the company's website at www.mn.com.tr

About GeneraMedix Inc.

GeneraMedix Inc. is a privately held pharmaceutical company offering high quality generic injectable products to the U.S. hospital and specialty markets. In addition to its products already marketed, GeneraMedix has a significant number of injectable products under development, as well as a number of products currently under FDA review. Headquartered in Liberty Corner, New Jersey, the company was founded in July of 2004. Additional information is available on the company's website at www.GeneraMedix.com.


Source: GeneraMedix

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.